4//SEC Filing
Jazz Pharmaceuticals plc 4
Accession 0001232524-15-000017
$JAZZCIK 0001232524operating
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 7:38 PM ET
Size
11.1 KB
Accession
0001232524-15-000017
Insider Transaction Report
Form 4
Tobias Jeffrey K
SVP of Research & Dev and CMO
Transactions
- Exercise/Conversion
Ordinary Shares
2015-02-10$46.83/sh+5,000$234,150→ 40,063 total - Sale
Ordinary Shares
2015-02-10$166.48/sh−3,000$499,446→ 37,063 total - Sale
Ordinary Shares
2015-02-10$167.34/sh−2,000$334,672→ 35,063 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2015-02-10−5,000→ 25,019 totalExercise: $46.83Exp: 2022-08-08→ Ordinary Shares (5,000 underlying)
Footnotes (5)
- [F1]Includes 123 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on November 28, 2014.
- [F2]The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $166.03 to $166.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $167.01 to $167.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F5]As of the date of this report, the remaining ordinary shares subject to this option are vested with respect to 2,682 shares and will vest with respect to 12,805 shares in equal monthly installments from March 9, 2015 to December 9, 2015 and with respect to 9,532 shares in equal monthly installments from January 9, 2016 to August 9, 2016.
Documents
Issuer
Jazz Pharmaceuticals plc
CIK 0001232524
Entity typeoperating
IncorporatedIreland
Related Parties
1- filerCIK 0001232524
Filing Metadata
- Form type
- 4
- Filed
- Feb 11, 7:00 PM ET
- Accepted
- Feb 12, 7:38 PM ET
- Size
- 11.1 KB